Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

PCOS is a major cause of infertility and requires personalized treatment.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Early treatment of PCOS is crucial for better health and quality of life.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.